COMMUNIQUÉS West-GlobeNewswire

T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018
LEXINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare [...]
Amicus Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference
01/06/2018
CRANBURY, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics , Inc. (Nasdaq:FOLD) announced today that John F. Crowley, Chairman and Chief Executive Officer, will participate in a corporate overview and [...]
Avivagen Announces Distribution in China for Vivamune
01/06/2018
OTTAWA, June 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK
01/06/2018
Inclusion in the Cancer Drugs Fund will give more women in England and Wales with recurrent, platinum-sensitive ovarian cancer access to ZEJULA via a managed access arrangement ZEJULA was launched in the private market [...]
Mauricio Graber commences as new CEO of Chr. Hansen Holding A/S
01/06/2018
Company Announcement No.10/2018 Attachment No 10 2018 US_new CEO
Solon Eiendom ASA : Primary insider notification
01/06/2018
(Oslo, Norway, May 31, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 9.366 shares in Solon Eiendom ASA at a price of NOK 30.00. Following this [...]
Shire plc : Rule 2.9 Announcement
01/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 June 2018 Shire [...]
DBV Technologies: Ordinary and Extraordinary General Meeting of June 22, 2018 - Procedures for Obtaining Preparatory Documents for the General Meeting
01/06/2018
Montrouge, France, June 1, 2018 Ordinary and Extraordinary General Meeting of June 22, 2018 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - [...]
DBV Technologies : Assemblée Générale Mixte du 22 juin 2018 - Modalités de mise à disposition des documents préparatoires à l'Assemblée
01/06/2018
Montrouge, France, le 1 juin (07h30 CEST) 2018 Assemblée Générale Mixte du 22 juin 2018 Modalités de mise à disposition des documents préparatoires à l'Assemblée DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - [...]
Vericel Corporation Prices $65 Million Public Offering of Common Stock
01/06/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/06/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]
Mount Tam Biotechnologies Announces Stockholder Approvals
31/05/2018
NOVATO, CA, May 31, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to [...]
Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference
31/05/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, [...]
Menlo Therapeutics to Present at Upcoming Investor Conferences
31/05/2018
REDWOOD CITY, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
Intuitive Surgical Announces Innovative Single Port Platform — the da Vinci SP® Surgical System
31/05/2018
Allows for narrow access surgery using a single port SUNNYVALE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), today announced a new U.S. Food and Drug Administration (FDA) clearance [...]
Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology
31/05/2018
Clinical Benefit of Tonmya, an FDA-Designated Breakthrough Therapy for PTSD, was Evidenced in AtEase NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), presented data [...]
Oncolytics Biotech® Announces Public Offering of Common Shares
31/05/2018
CALGARY, Alberta and SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (OTCQX:ONCYD), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus turning [...]
Reata Announces Orphan Drug Designation From the European Commission for Bardoxolone Methyl for the Treatment of Alport Syndrome
31/05/2018
IRVING, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission (EC) has granted orphan drug [...]
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
31/05/2018
CHARLESTON, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna [...]

Pages